Bio Protocol vs Linea — how do they compare? Bio Protocol trades at Rp513.41 (market cap Rp1,15T, Rp260,42M 24h volume), while Linea trades at Rp44.41 (market cap Rp994,72M, Rp288,97M 24h volume). The key difference: Bio Protocol is far larger — about 1156.1× Linea's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 22,3B / 72B LINEA (31%) for Linea. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Linea for 25 Days on average.
| BIO | LINEA | |
|---|---|---|
Market Cap | Rp1,15T | Rp994,72M |
Volume (24h) | Rp260,42M | Rp288,97M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 22,3B / 72B LINEA (31%) |
Typical Hold Time | 16 Days | 25 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
LINEA is currently trading at Rp44.965 with a bearish technical outlook, showing selling pressure across moving averages while oscillators remain neutral. The token faces immediate resistance at Rp44 with support at Rp42. With only 31% of max supply in circulation and average hold time of 25 days, the asset shows moderate distribution but limited recent fundamental developments.
Overall outlook remains cautious with technical weakness outweighing neutral momentum indicators. Key opportunity lies in potential bounce from support levels, while major risks include continued bearish momentum and limited ecosystem catalysts. Investors should monitor for protocol updates and exchange volume changes.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Linea is a Layer 2 network built to strengthen Ethereum and its economy. With ETH burn mechanics, native yield, and Ethereum-equivalent zk tech, Linea enhances the value and utility of Ethereum Mainnet. Backed by the largest ecosystem fund and trusted Ethereum builders, Linea offers institutional-grade infrastructure and deep DeFi integration—making it the best chain for ETH capital.
Read more on LINEA →